USE OF CD9 FOR A TARGET PROTEIN TO DEVELOPE ANTICANCER DRUG OF SOLID CANCERS THAT OVEREXPRESS CD9

摘要

PURPOSE: A CD9 as a target protein for developing anti-cancer drug for solid cancer in which CD9 is overexpressed is provided to increase cell viability, invasion and migration. CONSTITUTION: An anti-cancer drug contains CD9 inhibitor as an active ingredient. The CD9 inhibitor suppresses the growth, invasion, and migration of cancer cells. The CD9 inhibitor is selected from a group comprising antisense nucleotide which complementarily binds to mRNA, substrate analogue and antibody which bind to CD9, and a small compound which suppresses CD9 expression.